Anti-HIV agents: design and discovery of new potent RT inhibitors.
Maria Letizia Barreca, Alba Chimirri, Erik De Clercq, Laura De Luca, Anna-Maria Monforte, Pietro Monforte, Angela Rao, Maria Zappalà
文献索引：Il Farmaco 58 , 259-263, (2003)
全文：HTML全文
摘要
This paper reports our work in the field of nonnucleoside RT inhibitors (NNRTIs). On the basis of extensive studies on 1H,3H-thiazolo[3,4-a]benzimidazole derivatives (TBZs) followed by structure-activity relationship (SAR) considerations and molecular modeling, the design and synthesis of a series of 2,3-diaryl-1,3-thiazolidin-4-ones have been performed. Some derivatives proved to be highly effective in inhibiting human immunodeficiency virus type-1 (HIV-1) replication at nanomolar concentrations with minimal toxicity, acting as reverse transcriptase (RT) inhibitors. Computational studies were used in order to probe the binding of our ligands to HIV-1-RT.Copyright 2003 Editions scienctifiques et médicales Elsevier SAS
相关化合物
相关文献：
[Tetrahedron Lett. 46 , 2283, (2005)]
2005-01-07
[Chemistry 11(2) , 662-8, (2005)]
II. Derivatives of 2, 6-Diaminopyridine1. Bernstein J, et al.
[J. Am. Chem. Soc. 69(5) , 1151-115, (1947)]
Microwave-assisted synthesis of benzimidazole and thiazolidinone derivatives as HIV-1 RT inhibitors. Rao A, et al.
[ARKIVOC 147 , 155, (2004)]
Synthesis of “Acetylene-Expanded” Tridentate Ligands Holmes BT, et al.
[Molecules 7(5) , 447-455, (2002)]